GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tego Science Inc (XKRX:191420) » Definitions » EV-to-FCF

Tego Science (XKRX:191420) EV-to-FCF : -106.89 (As of May. 29, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Tego Science EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Tego Science's Enterprise Value is ₩131,017 Mil. Tego Science's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-1,226 Mil. Therefore, Tego Science's EV-to-FCF for today is -106.89.

The historical rank and industry rank for Tego Science's EV-to-FCF or its related term are showing as below:

XKRX:191420' s EV-to-FCF Range Over the Past 10 Years
Min: -13271.85   Med: -49.3   Max: 2990.1
Current: -103.49

During the past 11 years, the highest EV-to-FCF of Tego Science was 2990.10. The lowest was -13271.85. And the median was -49.30.

XKRX:191420's EV-to-FCF is ranked worse than
100% of 528 companies
in the Drug Manufacturers industry
Industry Median: 23.61 vs XKRX:191420: -103.49

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-29), Tego Science's stock price is ₩18770.00. Tego Science's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-332.253. Therefore, Tego Science's PE Ratio for today is At Loss.


Tego Science EV-to-FCF Historical Data

The historical data trend for Tego Science's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tego Science EV-to-FCF Chart

Tego Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,806.51 227.26 655.46 126.34 -36.45

Tego Science Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -99.35 -37.76 -19.68 -36.45 -130.15

Competitive Comparison of Tego Science's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Tego Science's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tego Science's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tego Science's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Tego Science's EV-to-FCF falls into.



Tego Science EV-to-FCF Calculation

Tego Science's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=131017.148/-1225.755
=-106.89

Tego Science's current Enterprise Value is ₩131,017 Mil.
Tego Science's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,226 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tego Science  (XKRX:191420) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Tego Science's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=18770.00/-332.253
=At Loss

Tego Science's share price for today is ₩18770.00.
Tego Science's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-332.253.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Tego Science EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Tego Science's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Tego Science (XKRX:191420) Business Description

Traded in Other Exchanges
N/A
Address
8, Maagok central, gangseo-gu, Seoul, KOR
Tego Science Inc is a biotech company that researches and develops regenerative medicine. It is engaged in the production of epidermis and cornea wound healing solution. Its products include Holoderm, SkinBank, Kaloderm, and Neoderm. It also provides testing services.

Tego Science (XKRX:191420) Headlines

No Headlines